Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
Clinical trial NCT02689843 · COMPLETED
Trial details
- NCT number
- NCT02689843
- Sponsor
- Shiraz University of Medical Sciences
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2018-11-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.